Y-mAbs Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Y-mAbs Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.08M, a 32.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.08M -$518K -32.5% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.27M +$93K +7.9% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.18M -$190K -13.9% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.41M -$327K -18.8% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $1.59M -$576K -26.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.18M -$1.2M -50.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.37M -$1.79M -56.6% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.74M -$2.1M -54.7% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $2.17M -$633K -22.6% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $2.38M -$1.02M -29.9% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $3.16M -$824K -20.7% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $3.84M -$727K -15.9% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.8M -$2.32M -45.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $3.4M +$1.64M +93.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.98M +$2.11M +113% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $4.57M +$2.58M +130% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $5.12M +$3.04M +146% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.76M -$458K -20.7% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.87M -$455K -19.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.99M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $2.09M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $2.22M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $2.32M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.